Literature DB >> 29136443

Derivation and External Validation of Prediction Models for Advanced Chronic Kidney Disease Following Acute Kidney Injury.

Matthew T James1,2,3,4, Neesh Pannu5, Brenda R Hemmelgarn1,2,3,4, Peter C Austin6,7, Zhi Tan1, Eric McArthur6, Braden J Manns1,2,3,4, Marcello Tonelli1,2,3,4, Ron Wald6,8, Robert R Quinn1,2,3,4, Pietro Ravani1,2,3,4, Amit X Garg6,9.   

Abstract

Importance: Some patients will develop chronic kidney disease after a hospitalization with acute kidney injury; however, no risk-prediction tools have been developed to identify high-risk patients requiring follow-up. Objective: To derive and validate predictive models for progression of acute kidney injury to advanced chronic kidney disease. Design, Setting, and Participants: Data from 2 population-based cohorts of patients with a prehospitalization estimated glomerular filtration rate (eGFR) of more than 45 mL/min/1.73 m2 and who had survived hospitalization with acute kidney injury (defined by a serum creatinine increase during hospitalization > 0.3 mg/dL or > 50% of their prehospitalization baseline), were used to derive and validate multivariable prediction models. The risk models were derived from 9973 patients hospitalized in Alberta, Canada (April 2004-March 2014, with follow-up to March 2015). The risk models were externally validated with data from a cohort of 2761 patients hospitalized in Ontario, Canada (June 2004-March 2012, with follow-up to March 2013). Exposures: Demographic, laboratory, and comorbidity variables measured prior to discharge. Main Outcomes and Measures: Advanced chronic kidney disease was defined by a sustained reduction in eGFR less than 30 mL/min/1.73 m2 for at least 3 months during the year after discharge. All participants were followed up for up to 1 year.
Results: The participants (mean [SD] age, 66 [15] years in the derivation and internal validation cohorts and 69 [11] years in the external validation cohort; 40%-43% women per cohort) had a mean (SD) baseline serum creatinine level of 1.0 (0.2) mg/dL and more than 20% had stage 2 or 3 acute kidney injury. Advanced chronic kidney disease developed in 408 (2.7%) of 9973 patients in the derivation cohort and 62 (2.2%) of 2761 patients in the external validation cohort. In the derivation cohort, 6 variables were independently associated with the outcome: older age, female sex, higher baseline serum creatinine value, albuminuria, greater severity of acute kidney injury, and higher serum creatinine value at discharge. In the external validation cohort, a multivariable model including these 6 variables had a C statistic of 0.81 (95% CI, 0.75-0.86) and improved discrimination and reclassification compared with reduced models that included age, sex, and discharge serum creatinine value alone (integrated discrimination improvement, 2.6%; 95% CI, 1.1%-4.0%; categorical net reclassification index, 13.5%; 95% CI, 1.9%-25.1%) or included age, sex, and acute kidney injury stage alone (integrated discrimination improvement, 8.0%; 95% CI, 5.1%-11.0%; categorical net reclassification index, 79.9%; 95% CI, 60.9%-98.9%). Conclusions and Relevance: A multivariable model using routine laboratory data was able to predict advanced chronic kidney disease following hospitalization with acute kidney injury. The utility of this model in clinical care requires further research.

Entities:  

Mesh:

Year:  2017        PMID: 29136443      PMCID: PMC5820711          DOI: 10.1001/jama.2017.16326

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  35 in total

1.  Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.

Authors:  Arsh K Jain; Meaghan S Cuerden; Ian McLeod; Brenda Hemmelgarn; Ayub Akbari; Marcello Tonelli; Rob R Quinn; Matt J Oliver; Amit X Garg
Journal:  Kidney Int       Date:  2012-03-21       Impact factor: 10.612

Review 2.  Surrogate end points for clinical trials of kidney disease progression.

Authors:  Lesley A Stevens; Tom Greene; Andrew S Levey
Journal:  Clin J Am Soc Nephrol       Date:  2006-06-14       Impact factor: 8.237

Review 3.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

4.  A predictive model for progression of chronic kidney disease to kidney failure.

Authors:  Navdeep Tangri; Lesley A Stevens; John Griffith; Hocine Tighiouart; Ognjenka Djurdjev; David Naimark; Adeera Levin; Andrew S Levey
Journal:  JAMA       Date:  2011-04-11       Impact factor: 56.272

5.  Relation between kidney function, proteinuria, and adverse outcomes.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Anita Lloyd; Matthew T James; Scott Klarenbach; Robert R Quinn; Natasha Wiebe; Marcello Tonelli
Journal:  JAMA       Date:  2010-02-03       Impact factor: 56.272

6.  Assessing the performance of prediction models: a framework for traditional and novel measures.

Authors:  Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

7.  Validation of a case definition to define hypertension using administrative data.

Authors:  Hude Quan; Nadia Khan; Brenda R Hemmelgarn; Karen Tu; Guanmin Chen; Norm Campbell; Michael D Hill; William A Ghali; Finlay A McAlister
Journal:  Hypertension       Date:  2009-10-26       Impact factor: 10.190

8.  Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures.

Authors:  Nancy R Cook; Paul M Ridker
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391

9.  Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD).

Authors:  Gary S Collins; Johannes B Reitsma; Douglas G Altman; Karel G M Moons
Journal:  Ann Intern Med       Date:  2015-05-19       Impact factor: 25.391

10.  Graphical assessment of internal and external calibration of logistic regression models by using loess smoothers.

Authors:  Peter C Austin; Ewout W Steyerberg
Journal:  Stat Med       Date:  2013-08-23       Impact factor: 2.373

View more
  41 in total

1.  Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression: The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study.

Authors:  Chi-Yuan Hsu; Vernon M Chinchilli; Steven Coca; Prasad Devarajan; Nasrollah Ghahramani; Alan S Go; Raymond K Hsu; T Alp Ikizler; James Kaufman; Kathleen D Liu; Chirag R Parikh; W Brian Reeves; Mark Wurfel; Michael Zappitelli; Paul L Kimmel; Edward D Siew
Journal:  JAMA Intern Med       Date:  2020-03-01       Impact factor: 21.873

2.  Does elevated urinary Dkkopf-3 level predict vulnerability to kidney injury during cardiac surgery?

Authors:  Matthew B Lanktree; York Pei
Journal:  Ann Transl Med       Date:  2019-12

3.  Improving Care for Patients after Hospitalization with AKI.

Authors:  Edward D Siew; Kathleen D Liu; John Bonn; Vernon Chinchilli; Laura M Dember; Timothy D Girard; Tom Greene; Adrian F Hernandez; T Alp Ikizler; Matthew T James; Kevin Kampschroer; Jeffrey B Kopp; Marla Levy; Paul M Palevsky; Neesh Pannu; Chirag R Parikh; Michael V Rocco; Samuel A Silver; Heather Thiessen-Philbrook; Ron Wald; Yining Xie; Paul L Kimmel; Robert A Star
Journal:  J Am Soc Nephrol       Date:  2020-09-10       Impact factor: 10.121

Review 4.  Long-Term Outcomes in Patients with Acute Kidney Injury.

Authors:  Rebecca A Noble; Bethany J Lucas; Nicholas M Selby
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-19       Impact factor: 8.237

5.  Results from the TRIBE-AKI Study found associations between post-operative blood biomarkers and risk of chronic kidney disease after cardiac surgery.

Authors:  Steven Menez; Dennis G Moledina; Amit X Garg; Heather Thiessen-Philbrook; Eric McArthur; Yaqi Jia; Caroline Liu; Wassim Obeid; Sherry G Mansour; Jay L Koyner; Michael G Shlipak; Francis P Wilson; Steven G Coca; Chirag R Parikh
Journal:  Kidney Int       Date:  2020-07-25       Impact factor: 10.612

6.  Association Between Preoperative Proteinuria and Postoperative Acute Kidney Injury and Readmission.

Authors:  Tyler S Wahl; Laura A Graham; Melanie S Morris; Joshua S Richman; Robert H Hollis; Caroline E Jones; Kamal M Itani; Todd H Wagner; Hillary J Mull; Jeffrey C Whittle; Gordon L Telford; Amy K Rosen; Laurel A Copeland; Edith A Burns; Mary T Hawn
Journal:  JAMA Surg       Date:  2018-09-19       Impact factor: 14.766

7.  Mapping and functional characterization of murine kidney injury molecule-1 proteolytic cleavage site.

Authors:  Saranga Sriranganathan; Elena Tutunea-Fatan; Alina Abbasi; Lakshman Gunaratnam
Journal:  Mol Cell Biochem       Date:  2020-11-19       Impact factor: 3.396

8.  Incidence of Serum Creatinine Monitoring and Outpatient Visit Follow-Up among Acute Kidney Injury Survivors after Discharge: A Population-Based Cohort Study.

Authors:  Erin F Barreto; Diana J Schreier; Heather P May; Kristin C Mara; Alanna M Chamberlain; Kianoush B Kashani; Shannon L Piche; Chung-Il Wi; Sandra L Kane-Gill; Victoria T Smith; Andrew D Rule
Journal:  Am J Nephrol       Date:  2021-11-02       Impact factor: 3.754

9.  How combining different caries lesions characteristics may be helpful in short-term caries progression prediction: model development on occlusal surfaces of primary teeth.

Authors:  Isabela Floriano; Elizabeth Souza Rocha; Ronilza Matos; Juliana Mattos-Silveira; Kim Rud Ekstrand; Fausto Medeiros Mendes; Mariana Minatel Braga
Journal:  BMC Oral Health       Date:  2021-05-12       Impact factor: 2.757

10.  Long-term kidney function of patients discharged from hospital after an intensive care admission: observational cohort study.

Authors:  Ryan W Haines; Jonah Powell-Tuck; Hugh Leonard; Siobhan Crichton; Marlies Ostermann
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.